[New oral anticoagulants and prostate biopsy: Which usual precaution should we use?].

Date publication

juillet 2015

Journal

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie

Auteurs

Membres identifiés du Cancéropôle Est :
Pr NGUYEN Philippe

Tous les auteurs :
Coscarella M, Viart L, Nguyen P, Saint F

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/25957818

Résumé

In 2013, more than 30,000 prostate biopsies have been performed in France. Bleeding complications are not rare. It imposes meticulous perioperative management in order to avoid them. In a close future, new oral anticoagulants (NOAC) will probably substitute vitamin K antagonist in many indications. The management of these new drugs is not really familiar in urology. The authors have specified it by using a systematic literature search in association to guidelines analysis edited by learned society.

Mots clés

Administration, Oral, Anticoagulants, administration & dosage, Biopsy, Drug Administration Schedule, Hemorrhage, etiology, Humans, Male, Perioperative Care, Practice Guidelines as Topic, Prostate, pathology

Référence

Prog. Urol.. 2015 Jul;25(9):510-5